Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Feb 1, 2017
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-01-30+130,000→ 130,000 totalExercise: $6.35From: 2017-01-30Exp: 2026-02-03→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]On February 4, 2016, the reporting person was granted an option to purchase 130,000 shares of common stock. The option vests only upon achievement of a performance-based milestone. The performance criteria were met on January 30, 2017, resulting in vesting of the option. Upon achievement of the milestone, fifty percent of the shares immediately vest with the remaining shares vesting over the 24 month period following the vesting commencement date, subject to the reporting person's continuous service to Regulus.